Publication: COVID-19 may enhance risk of thrombosis and hemolysis in the G6PD deficient patients
Loading...
Program
KU-Authors
Organization Authors
Co-Authors
Dağlıoğlu, Gülçin
Candevir, Aslıhan
Kurtaran, Behice
Bozdoğan, Sevcan Tan
İnal, Tamer Cevat
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
COVID-19 has become a major public health problem since December, 2019 and no highly effective drug has been found until now. Numbers of infected people and deaths by COVID-19 are increasing every day worldwide, therefore self-isolation and protection are highly recommended to prevent the spread of the virus and especially to protect major risk groups such as the elderly population and people with comorbidities including diabetes, hypertension, cancer, cardiovascular diseases and metabolic syndrome. on the other hand, young people without any secondary disease have died by COVID-19 as well. In this study we compared two male patients infected by COVID-19 at the same age and one of them was diagnosed with G6PD deficiency. Both COVID-19and G6PD deficiency enhance the risk of hemolysis and thrombosis. Serum biochemistry, hemogram and immunological parameters showed that risk of hemolysis and thrombosis may increase in the G6PD deficient patient infected by COVID-19.
Source
Publisher
Taylor & Francis Inc
Citation
item.page.haspartof
Source
Nucleosides Nucleotides and Nucleic Acids
item.page.ispartofseries
item.page.edition
DOI
10.1080/15257770.2021.1897457
item.page.datauri
item.page.link
Rights
N/A
Copyrights Note
Rights and licensing
N/A
